Mitsubishi UFJ Asset Management Portfolio holdings
AUM
$125B
1-Year Return
23.89%
This Quarter Return
+14.63%
1 Year Return
+23.89%
3 Year Return
+93.04%
5 Year Return
+163.06%
10 Year Return
+400.91%
AUM
$4.86B
AUM Growth
+$886M
(+22%)
Cap. Flow
+$232M
Cap. Flow
% of AUM
4.78%
Top 10 Holdings %
Top 10 Hldgs %
20.04%
Holding
933
New
16
Increased
730
Reduced
81
Closed
8
Top Buys
| 1 |
Home Depot
HD
|
$26.4M |
| 2 |
American Express
AXP
|
$17.8M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
$14.7M |
| 4 |
Walt Disney
DIS
|
$12.8M |
| 5 |
CME Group
CME
|
$12.8M |
Top Sells
| 1 |
McDonald's
MCD
|
$22.2M |
| 2 |
MSCI
MSCI
|
$15.2M |
| 3 |
Boeing
BA
|
$14M |
| 4 |
Johnson & Johnson
JNJ
|
$13.9M |
| 5 |
JPMorgan Chase
JPM
|
$13.8M |
Sector Composition
| 1 | Technology | 17.52% |
| 2 | Healthcare | 13.61% |
| 3 | Financials | 13.35% |
| 4 | Consumer Discretionary | 11.14% |
| 5 | Industrials | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
826
Qiagen
QGEN
$10.3B
| $154K | ﹤0.01% |
3,572
+245
| +7% | +$10.6K |
|
827
Iovance Biotherapeutics
IOVA
$829M
| $153K | ﹤0.01% |
16,122
+748
| +5% | +$7.1K |
|
828
Ultra Clean Holdings
UCTT
$1.11B
| $153K | ﹤0.01% |
14,808
+1,372
| +10% | +$14.2K |
|
829
Intellia Therapeutics
NTLA
$1.28B
| $152K | ﹤0.01% |
8,910
+529
| +6% | +$9.02K |
|
830
Smith & Nephew
SNN
$16.7B
| $152K | ﹤0.01% |
3,789
+416
| +12% | +$16.7K |
|
831
CRISPR Therapeutics
CRSP
$4.85B
| $151K | ﹤0.01% |
4,220
+233
| +6% | +$8.34K |
|
832
Innovative Industrial Properties
IIPR
$1.61B
| $151K | ﹤0.01% |
1,850
| – | – |
|
833
GoPro
GPRO
$244M
| $149K | ﹤0.01% |
22,863
+2,021
| +10% | +$13.2K |
|
|
NXRT
834
NexPoint Residential Trust
NXRT
$879M
| $149K | ﹤0.01% |
3,885
| – | – |
|
835
Regenxbio
RGNX
$493M
| $149K | ﹤0.01% |
2,594
+225
| +9% | +$12.9K |
|
|
FSP
836
Franklin Street Properties
FSP
$179M
| $147K | ﹤0.01% |
20,396
| – | – |
|
837
Abeona Therapeutics
ABEO
$356M
| $144K | ﹤0.01% |
781
+52
| +7% | +$9.59K |
|
838
Forum Energy Technologies
FET
$316M
| $143K | ﹤0.01% |
1,401
+210
| +18% | +$21.4K |
|
839
AeroVironment
AVAV
$11.4B
| $142K | ﹤0.01% |
2,078
+259
| +14% | +$17.7K |
|
840
Camtek
CAMT
$3.64B
| $142K | ﹤0.01% |
15,921
+508
| +3% | +$4.53K |
|
841
Sangamo Therapeutics
SGMO
$165M
| $141K | ﹤0.01% |
14,732
+768
| +5% | +$7.35K |
|
|
HIFR
842
DELISTED
InfraREIT, Inc.
HIFR
| $140K | ﹤0.01% |
6,695
| – | – |
|
843
Editas Medicine
EDIT
$234M
| $139K | ﹤0.01% |
5,697
+537
| +10% | +$13.1K |
|
|
CSR
844
Centerspace
CSR
$1.01B
| $138K | ﹤0.01% |
2,298
| – | – |
|
845
AngioDynamics
ANGO
$442M
| $137K | ﹤0.01% |
6,000
+200
| +3% | +$4.57K |
|
846
TTM Technologies
TTMI
$4.99B
| $136K | ﹤0.01% |
11,606
+1,515
| +15% | +$17.8K |
|
847
Novartis
NVS
$252B
| $134K | ﹤0.01% |
1,553
+136
| +10% | +$11.7K |
|
848
NVE Corp
NVEC
$322M
| $132K | ﹤0.01% |
1,347
+45
| +3% | +$4.41K |
|
849
STMicroelectronics
STM
$24B
| $130K | ﹤0.01% |
8,737
+547
| +7% | +$8.14K |
|
|
CLLS
850
Cellectis
CLLS
$262M
| $128K | ﹤0.01% |
6,998
+453
| +7% | +$8.29K |
|